1 2 People who both smoke and are obese are at particularly high risk for cardiovascular disease and need to tackle both of these issues. Smoking cessation can be diYcult to achieve in obese people because of concerns over weight gain.
3 4 However, it is unclear whether weight loss among smokers produces the same cardiovascular benefits as in non-smokers.
In this study we attempt to: (1) determine whether smokers and non-smokers entering a weight loss programme diVer with respect to cardiovascular risk factors and (2) determine whether smokers and non-smokers obtain the same level of benefit from a weight loss programme with respect to cardiovascular risk factor improvement.
Methods
The Weight Management Clinic at the Ottawa Hospital-Civic Campus oVers a one year physician monitored comprehensive weight loss programme to people with high risk obesity. High risk obesity is defined as a body mass index (BMI) greater than 35 or between 30 and 35 with evidence of obesity comorbidity or presence of other cardiovascular risk factors. The programme consists of a 12 month course in lifestyle modification combined with a 13 week 900 kcal total meal replacement (Optifast 900). Background demographic data and smoking data are obtained on all patients before the first week. Weight and blood pressure are followed up weekly. Fasting serum lipid profile (total cholesterol, high density lipoprotein (HDL), low density lipoprotein (LDL) and triglyceride) is obtained at 1 and 13 weeks.
We analysed data on all patients entered into the database from September 1992 to January 2000 on whom smoking status was available. We identified smokers as those admitting to smoking one or more cigarettes at the time of their initial assessment. We determined diVerences in baseline characteristics and changes in BMI, waist circumference, mean arterial pressure (MAP) and cholesterol profile at 13 weeks between smokers and non-smokers using Student's t tests and regression analysis ( 2 tests were used to compare proportions of men and women). A linear regression model for change in BMI was developed using a forward stepwise method with a p value of 0.05 for addition or removal of variables. The statistical program used for all analyses was SPSS version 8.0.
Results
The database contained smoking information on 968 people, including 119 smokers and 849 non-smokers (table 1) . Sixty three per cent of those classified as smokers admitted to smoking more than 10 cigarettes/day. Smokers were significantly younger than non-smokers (41.3 and 45.3, p<0.001), had a significantly larger initial waist size (47.5 and 47.2, p=0.01) and had a significantly lower HDL level (1.06 and 1.18, p< 0.001). Smokers also had a statistically significant smaller reduction in BMI (16.8% and 17.6%, p=0.02). There was no significant diVerence in changes in waist circumference (−13.6% and −14.6%), MAP (−7.2% and −7.4%), HDL (+4.8% and +0.4%), LDL (−22.1% and −23.6%) or triglyceride level (−26.9% and −31.2%) at 13 weeks between smokers and non-smokers. Limitations of this analysis are attributable to the fact that smoking status was based on self report and that smoking status may have changed between initial assessment and week 13.
Conclusion
Smokers seem to derive the same benefit as non-smokers from a structured weight loss programme with respect to change in waist measurement, reduction in blood pressure and improvement in cholesterol profile. While the change in BMI between smokers and nonsmokers was statistically significant, the less than 1% diVerence is probably not clinically significant. The results of this study suggest that weight loss among smokers does provide benefit and need not be delayed until smoking cessation has been achieved. The decision of whether to stop smoking or lose weight first is ultimately one that should be left to the patient after consultation with their health care provider.
